Abrogated USP7 expression promotes CD8+ T cell proliferation, elevates tumor necrosis factor (TNF) alpha and interferon gamma (IFN-γ) levels, and inhibits glioma cell immune evasion, which can be reversed by PD-L1 overexpression (18). This evidence concerns the gene USP7 and central nervous system cancer.